Auricle is a medical device company focused on developing a breakthrough neurostimulation implant designed to restore hearing in patients who no longer benefit from hearing aids but are not ready for cochlear implants. The company's innovative approach aims to preserve remaining natural hearing through a reversible and less invasive surgery, addressing key patient concerns associated with cochlear implants. Auricle's mission is to provide an effective alternative for millions of patients worldwide.
Founded out of Stanford Biodesign, Auricle has garnered support from prominent organizations such as Y Combinator, StartX, and Fogarty Innovation. These affiliations have helped the company make significant strides in its mission to revolutionize hearing restoration. Auricle's impact is underscored by its commitment to improving the quality of life for individuals with hearing impairments through cutting-edge technology and patient-centered solutions.
